Nancy E Hynes

发表

Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers.

H. Esumi, N. Hynes, G. Pagès, 2002, Molecular biology of the cell.

The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.

H. Lane, N. Hynes, Nancy E Hynes, 2002, Cancer research.

Tyrosine kinase signalling in breast cancer

N. Hynes, Nancy E Hynes, 2000, Breast Cancer Research.

The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancer.

Christine Stephan, Michael Stumm, Cathrin Brisken, 2008, Cancer research.

ErbB receptors: directing key signaling networks throughout life.

N. Hynes, T. Holbro, Nancy E Hynes, 2004, Annual review of pharmacology and toxicology.

ErbB receptors and signaling pathways in cancer.

N. Hynes, Nancy E Hynes, Gwen MacDonald, 2009, Current opinion in cell biology.

WNT signaling enhances breast cancer cell motility and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231 xenograft growth

Edward J Oakeley, Yutaka Matsuda, T. Schlange, 2009, Breast Cancer Research.

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation

Yutaka Matsuda, T. Schlange, N. Hynes, 2007, Breast Cancer Research.

TEL/ETV6 Is a Signal Transducer and Activator of Transcription 3 (Stat3)-induced Repressor of Stat3 Activity*

Edward J Oakeley, E. Oakeley, N. Hynes, 2004, Journal of Biological Chemistry.

Key signalling nodes in mammary gland development and cancer: Myc

N. Hynes, Nancy E Hynes, Tina Stoelzle, 2009, Breast Cancer Research.

The ErbB receptors and their role in cancer progression.

N. Hynes, T. Holbro, G. Civenni, 2003, Experimental cell research.

Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins

N. Hynes, M. Koziczak, T. Holbro, 2004, Oncogene.